$KNSA News

Kiniksa Pharmaceuticals (NASDAQ:KNSA): High Growth Momentum Meets a Breakout Setup

Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Pairs Strong Growth With a High-Quality Technical Setup

Kiniksa Pharmaceuticals (NASDAQ:KNSA): Affordable Growth Backed by Accelerating Earnings

Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Pairs High Growth Momentum With a Breakout Setup

Kiniksa Pharmaceuticals International (KNSA) On The ARCALYST Story And Whether Shares Look Fully Valued

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Meets Minervini Trend Template and High-Growth Momentum Criteria

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines Strong Growth With a High-Quality Technical Setup

Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat

Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with a Breakout Setup

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shows Strong Growth and a Technical Setup for a Potential Breakout

Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan

Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Compelling Affordable Growth Story

Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

Kiniksa Pharmaceuticals International, plc 2026 Q2 - Results - Earnings Call Presentation

Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?